IONS vs TREX · rev $514.0M vs P/E 25, rev $761.4M
Ionis Pharmaceuticals Inc (IONS) versus Trex Company Inc (TREX) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Trex Company Inc (TREX) is a building products & equipment company listed on NYSE.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported TREX revenue for 2026-06-30 was $761.4M. Net income was $123.3M. TREX currently screens at market cap $4.72B and trailing P/E 25.3.
IONS currently screens at market cap $12.28B. TREX currently screens at market cap $4.72B and trailing P/E 25.3.
Not investment advice. Open the IONS and TREX stock pages for the full models.
Not investment advice.